Remineralization of Early Carious Lesion Using Natural Agents Versus Bioadhesive Polymers

Sponsor
Al-Azhar University (Other)
Overall Status
Completed
CT.gov ID
NCT04390256
Collaborator
(none)
60
1
4
35.3
1.7

Study Details

Study Description

Brief Summary

This study will be conducted to evaluate:
  1. The remineralization potential of natural agents (egg shell powder and clove extract) versus bioadhesive polymers (carbopol and carboxymethyl cellulose) with or without PH cycling using microhardness test.

  2. The clinical efficacy of all agents in patients with early carious lesions.

Condition or Disease Intervention/Treatment Phase
  • Other: Clove water extract
  • Other: Carbopol
  • Other: Carboxymethyle cellulose
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Remineralization of Early Carious Lesion Using Natural Agents Versus Bioadhesive Polymers
Actual Study Start Date :
Jun 1, 2017
Actual Primary Completion Date :
Jan 10, 2020
Actual Study Completion Date :
May 10, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Egg shell powder nanoparticles

Other: Clove water extract
natural product

Other: Carbopol
Bioadhesive polymer

Other: Carboxymethyle cellulose
Bioadhesive polymer

Experimental: Clove water extract

Other: Clove water extract
natural product

Other: Carbopol
Bioadhesive polymer

Other: Carboxymethyle cellulose
Bioadhesive polymer

Experimental: Carbopol

Other: Clove water extract
natural product

Other: Carbopol
Bioadhesive polymer

Other: Carboxymethyle cellulose
Bioadhesive polymer

Experimental: Carboxymethyle cellulose

Other: Clove water extract
natural product

Other: Carbopol
Bioadhesive polymer

Other: Carboxymethyle cellulose
Bioadhesive polymer

Outcome Measures

Primary Outcome Measures

  1. Remineralization of enamel [3 months]

    Remineralization of enamel using Vista scan

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
    1. Criteria related to patient:
  • Age's eligible for trial was 18- 30 years.

  • Patient able to read and sign the informed consent form.

  • Cooperative patient who are willing to participate and able to continue the schedule time of wok keep good oral hygiene throughout the study.

  • Healthy volunteers.

  • Patient with moderate and high caries index. 2. Criteria related to tooth:

  • Patient with at least 2 white lesions (WSL) detected clinically on the buccal surface of permanent anterior teeth, one on each side. WSL selected either due to caries or orthodontic treatment (just following deboning).

  • Teeth with score1, 2, 3 according to ICDAS II.

  • Absence of preoperative pain, no mobility & tenderness on percussion.

  • Radiographically, the pre-operative inclusion criteria were absence of internal or external resorption, no periapical radiolucencies and no widening of periodontal ligament space..

Exclusion Criteria:
    1. Criteria related to patient:
  • Patient with Rampant uncontrolled caries.

  • Patient with compromised medical history.

  • Pregnant or breast feeding females.

  • Heavy smoker.

  • Patient who currently received extensive fluoride regiments for treatment of WSL.

  • Patients who planned to move within 3 months of enrollment.

  • Patient with evidence of xerostomia. 2. Criteria related to tooth:

  • Teeth with score 4, 5 according to ICDAS II.

  • Teeth with periapical pathology, internal or external resorption or exhibiting any symptoms of pulp pathology.

  • Teeth with questionable vitality or have root canal therapy.

  • Teeth have been pulp capped.

  • Teeth with periodontal pocket and bleeding on probing.

  • Cracked teeth.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Al Azhar university Cairo Egypt

Sponsors and Collaborators

  • Al-Azhar University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Marwa Mohamed, Ass. lecturer, Al-Azhar University
ClinicalTrials.gov Identifier:
NCT04390256
Other Study ID Numbers:
  • REC17-030
First Posted:
May 15, 2020
Last Update Posted:
May 15, 2020
Last Verified:
May 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 15, 2020